Benchmarking Rare Disease Field Medical Excellence in Europe: Establishing Standards for High Performance & Impact

KEY TOPICS

• Effective Rare Disease Field Performance Metrics in Europe
• Building a Rare Disease Field Medical Excellence Framework
• Target and Engagement Levels of Rare Disease KOLs in Europe
• Average Time Spent by Rare Disease MSLs on KOL Interactions and Internal Activities in Europe
• Rare Disease Field Medical Staffing Footprint in Europe
• Key Insights and Lessons Learned for Measuring the Impact of Rare Disease MSLs in Europe

• Europe field scorecard: Benchmarking rare disease engagements
• Average number of tiered vs. non-tiered KOLs per rare disease MSL in Europe
• Monthly KOL and F2F interactions in Europe – Rare disease segment
• Weighting criteria for various interaction types on the rare disease MSL scorecard (Europe)
• Metrics for engaging non-tiered rare disease KOLs in Europe
• Average rare disease MSL time in the field (days per year) in Europe
• Percentage of rare disease MSL time spent on external, internal, and logistics activities in Europe
• Weekly rare disease MSL time allocation for each activity stream in Europe
• Percentage of overall rare disease targets classified as KOLs, HCPs, payers, or other external stakeholders in Europe
• Rare disease field medical staffing footprint in Europe

• Emphasis on F2F Interactions in Europe: Rare diseases field medical teams in Europe assign higher value to Face-to-Face (F2F) interactions, recognizing their significant impact on the overall MSL scorecard. This emphasis underscores the profound impact such engagements wield in fostering meaningful connections and driving key metrics forward.

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.